Point View Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1M Buy
17,226
+1,694
+11% +$102K 0.41% 79
2020
Q3
$981K Buy
15,532
+346
+2% +$24K 0.46% 71
2020
Q2
$1.17M Sell
15,186
-1,545
-9% -$118K 0.56% 55
2020
Q1
$1.25M Buy
16,731
+2,440
+17% +$169K 0.69% 43
2019
Q4
$929K Buy
14,291
+718
+5% +$46.8K 0.38% 94
2019
Q3
$860K Sell
13,573
-851
-6% -$55.6K 0.39% 86
2019
Q2
$974K Buy
14,424
+49
+0.3% +$3.22K 0.41% 80
2019
Q1
$935K Buy
14,375
+1,802
+14% +$120K 0.42% 80
2018
Q4
$786K Buy
12,573
+1,849
+17% +$129K 0.4% 88
2018
Q3
$828K Buy
10,724
+772
+8% +$58.3K 0.37% 93
2018
Q2
$705K Buy
9,952
+214
+2% +$15.1K 0.33% 110
2018
Q1
$734K Buy
9,738
+405
+4% +$32.2K 0.35% 101
2017
Q4
$669K Sell
9,333
-1,714
-16% -$130K 0.32% 113
2017
Q3
$895K Buy
11,047
+1,582
+17% +$121K 0.43% 82
2017
Q2
$670K Buy
9,465
+1,614
+21% +$107K 0.33% 112
2017
Q1
$533K Buy
7,851
+1,385
+21% +$97.4K 0.27% 131
2016
Q4
$463K Buy
6,466
+3,421
+112% +$254K 0.27% 133
2016
Q3
$241K Buy
3,045
+127
+4% +$10.3K 0.14% 185
2016
Q2
$243K Sell
2,918
-59
-2% -$5.24K 0.15% 189
2016
Q1
$273K Buy
+2,977
New +$268K 0.18% 167

Other funds holding GILD

Point View Wealth Management's GILD Position: Q4 2020 in Review

Point View Wealth Management increased its Gilead Sciences (GILD) stake by 11% in Q4 2020, buying an estimated $102K and bringing the position to 17,226 shares worth $1M. The position accounts for 0.41% of the portfolio, ranked #79.

Point View Wealth Management first reported a position in GILD in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.25M in Q1 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Point View Wealth Management held 17,226 shares of Gilead Sciences worth $1M as of Q4 2020.
  • Point View Wealth Management bought 1,694 Gilead Sciences shares in Q4 2020, an estimated $102K.
  • Gilead Sciences made up 0.41% of Point View Wealth Management's portfolio in Q4 2020, its #79 holding.
  • Point View Wealth Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 20 quarters since.
  • Point View Wealth Management's Gilead Sciences position peaked at $1.25M in Q1 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.